FHCO Insider Trading Activity and SEC Form 4 Filings
FHCO insider trading summary
No open-market insider purchases or sales of Female Health Co (FHCO) have been reported on SEC Form 4 in the past 12 months.
Latest FHCO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 12, 2017 | Mitchell Shuster Steiner | President and CEO | Buy | $19K (15,000 @ $1.26) |
| Jun 9, 2017 | Mitchell Shuster Steiner | President and CEO | Buy | $51K (40,000 @ $1.28) |
| Jun 9, 2017 | Elgar Peerschke | Director | Buy | $63K (50,000 @ $1.25) |
| Jun 8, 2017 | Elgar Peerschke | Director | Buy | $2K (1,915 @ $1.15) |
| Jun 7, 2017 | Elgar Peerschke | Director | Buy | $4K (3,052 @ $1.15) |
| Jun 7, 2017 | Daniel Haines | Chief Financial Officer | Buy | $7K (6,000 @ $1.14) |
| Jun 6, 2017 | Elgar Peerschke | Director | Buy | $3K (2,852 @ $1.15) |
| Jun 1, 2017 | Daniel Haines | Chief Financial Officer | Buy | $11K (10,000 @ $1.10) |
| May 30, 2017 | Harry Fisch | Director | Buy | $15K (12,000 @ $1.27) |
| May 24, 2017 | Harry Fisch | Director | Buy | $11K (10,000 @ $1.10) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.